FDA asks drugmaker to stop selling its opioid painkiller

U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market. The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER. It’s the first time the FDA has asked for the removal of an opioid painkiller. Endo had touted the new […]